Abstract
Effects of ATP, adenosine and purinoceptor antagonists on field stimulation-evoked (3 Hz, 2 min) [3H]-noradrenaline overflow were investigated in the rat isolated iris. ATP and adenosine inhibited the evoked overflow of [3H]-noradrenaline. 1,3-Dipropyl-8-cyclopentylxanthine (DPCPX) shifted the concentration-response curve of ATP to the right in a concentration-dependent manner, but with a potency (-log KB = 7.88) much lower than expected for an A1 adenosine receptor. In the continuous presence of DPCPX, the ATP-induced prejunctional inhibition was unaffected by suramin (100 mumol/l) and DIDS (4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid, 50 mumol/l) but was antagonized by the P2Y-receptor antagonist cibacron blue (= reactive blue 2; 30 and 100 mumol/l, -log KB = 4.7) and alpha,beta-methylene-ATP (10 mumol/l). Whereas the evoked [3H]-noradrenaline overflow was unaffected by suramin and DIDS, cibacron blue and alpha,beta-methylene-ATP caused a small and transient increase. Cibacron blue at 30 mumol/l failed to antagonize the inhibition of evoked [3H]-noradrenaline overflow that adenosine produced in the absence of DPCPX. Basal [3H]-noradrenaline overflow was enhanced by cibacron blue, not changed by alpha,beta-methylene-ATP and DIDS, and decreased by suramin. The results show that exogenous ATP inhibits sympathetic neurotransmission in the rat iris via A1 and P2Y-like purinoceptors. The latter have a low apparent affinity for cibacron blue and probably are blocked by alpha,beta-methylene-ATP. Under the present conditions, endogenous purines exert a tonic inhibition not only via A1- but also via these P2Y-receptors.
MeSH Terms
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid/pharmacology
Adenosine/pharmacology
Adenosine Triphosphate/analogs & derivatives,pharmacology
Animals
Electric Stimulation
In Vitro Techniques
Iris/metabolism
Norepinephrine/metabolism
Protein Synthesis Inhibitors/pharmacology
Purinergic P1 Receptor Antagonists
Purinergic P2 Receptor Antagonists
Rats
Rats, Wistar
Receptors, Purinergic P1/drug effects
Receptors, Purinergic P2/drug effects
Suramin/pharmacology
Synaptic Transmission/drug effects
Triazines/pharmacology
Xanthines/pharmacology
Chemicals
Protein Synthesis Inhibitors
Purinergic P1 Receptor Antagonists
Purinergic P2 Receptor Antagonists
Receptors, Purinergic P1
Receptors, Purinergic P2
Triazines
Xanthines
Cibacron Blue F 3GA
Suramin
Adenosine Triphosphate
1,3-dipropyl-8-cyclopentylxanthine
Adenosine
alpha,beta-methyleneadenosine 5'-triphosphate
4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid
Norepinephrine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Fuder H
Pharmakologisches Institut, Universität Mainz, Germany.
Muth U
References (34)
34 references, click to expand
-
Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.
J Med Chem. 1992 Feb 7;35(3):407-22
PMID: 1738138
-
Evidence for a vasoconstriction-mediating receptor for UTP, distinct from the P2 purinoceptor, in rabbit ear artery.
Naunyn Schmiedebergs Arch Pharmacol. 1987 Nov;336(5):556-60
PMID: 3437923
-
Different P2-purinergic receptor subtypes of endothelium and smooth muscle in canine blood vessels.
J Pharmacol Exp Ther. 1987 May;241(2):501-6
PMID: 3572809
-
Activation of P1- and P2Y-purinoceptors by ADP-ribose in the guinea-pig taenia coli, but not of P2X-purinoceptors in the vas deferens.
Br J Pharmacol. 1992 Oct;107(2):367-74
PMID: 1422586
-
Nucleotide modulation of norepinephrine release from sympathetic nerves in the rat vas deferens.
J Pharmacol Exp Ther. 1991 Mar;256(3):821-6
PMID: 1672377
-
Effects of suramin on the concentration--response relationship of alpha, beta-methylene ATP on the mouse vas deferens.
J Auton Pharmacol. 1991 Feb;11(1):45-9
PMID: 2030108
-
Purinoceptors mediating relaxation and spasm in the rat gastric fundus.
Br J Pharmacol. 1992 Jun;106(2):395-403
PMID: 1393267
-
Discrimination between two types of P2 purinoceptors by suramin in rat hepatocytes.
Eur J Pharmacol. 1992 Aug 3;226(4):363-5
PMID: 1397062
-
Some quantitative uses of drug antagonists.
Br J Pharmacol Chemother. 1959 Mar;14(1):48-58
PMID: 13651579
-
Preferential metabolism of (-) 3 H-norepinephrine through the deaminated glycol in the rat vas deferens.
Biochem Pharmacol. 1973 May 15;22(10):1147-60
PMID: 4707598
-
Stable adenine nucleotides inhibit [3H]-noradrenaline release in rabbit brain cortex slices by direct action at presynaptic adenosine A1-receptors.
Naunyn Schmiedebergs Arch Pharmacol. 1992 Aug;346(2):187-96
PMID: 1448182
-
Noradrenaline and ATP as cotransmitters in sympathetic nerves.
Neurochem Int. 1990;17(2):357-68
PMID: 20504636
-
Modulation of neurotransmitter release by presynaptic autoreceptors.
Physiol Rev. 1989 Jul;69(3):864-989
PMID: 2568648
-
Effects of ATP antagonists on purinoceptor-operated inward currents in rat phaeochromocytoma cells.
Pflugers Arch. 1991 Apr;418(3):214-9
PMID: 1713323
-
P2-purinoceptor antagonists.
Ann N Y Acad Sci. 1990;603:182-96; discussion 196-7
PMID: 2291520
-
Suramin antagonizes responses to P2-purinoceptor agonists and purinergic nerve stimulation in the guinea-pig urinary bladder and taenia coli.
Br J Pharmacol. 1990 Mar;99(3):617-21
PMID: 2331585
-
Inhibition by nucleotides acting at presynaptic P2-receptors of sympathetic neuro-effector transmission in the mouse isolated vas deferens.
Naunyn Schmiedebergs Arch Pharmacol. 1989 Nov;340(5):522-32
PMID: 2559333
-
Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery.
Br J Pharmacol. 1990 Nov;101(3):645-9
PMID: 2076483
-
A receptor that is highly specific for extracellular ATP in developing chick skeletal muscle in vitro.
Br J Pharmacol. 1991 Aug;103(4):1963-9
PMID: 1912983
-
Neuroeffector mechanisms.
Annu Rev Physiol. 1980;42:383-97
PMID: 6250455
-
Extracellular MgATP activates the Cl-/HCO3- exchanger in single rat cardiac cells.
J Physiol. 1991 Dec;444:241-56
PMID: 1822550
-
P2-purinoceptors of two subtypes in the rabbit mesenteric artery: reactive blue 2 selectively inhibits responses mediated via the P2y-but not the P2x-purinoceptor.
Br J Pharmacol. 1987 Feb;90(2):383-91
PMID: 3828656
-
Noradrenaline-ATP co-transmission in the sympathetic nervous system.
Trends Pharmacol Sci. 1991 Sep;12(9):319-24
PMID: 1658999
-
Cardiovascular purinoceptors.
Physiol Rev. 1990 Jul;70(3):761-845
PMID: 2194223
-
Pharmacology and electrophysiology of ATP-activated ion channels.
Trends Pharmacol Sci. 1992 Mar;13(3):87-90
PMID: 1374198
-
Recent developments in the classification and functional significance of receptors for ATP and UTP, evidence for nucleotide receptors.
Life Sci. 1992;50(22):1657-64
PMID: 1316981
-
Neuronal ATP receptors and their mechanism of action.
Trends Pharmacol Sci. 1993 Feb;14(2):50-4
PMID: 8480374
-
Adenosine triphosphate-evoked currents in cultured neurones dissociated from rat parasympathetic cardiac ganglia.
J Physiol. 1991 Mar;434:239-56
PMID: 1708820
-
Effect of presynaptic P2 receptor stimulation on transmitter release.
J Neurochem. 1991 May;56(5):1466-70
PMID: 1672880
-
Further subclassification of ATP receptors based on agonist studies.
Trends Pharmacol Sci. 1991 Apr;12(4):137-41
PMID: 2063479
-
Antagonism by reactive blue 2 but not by brilliant blue G of extracellular ATP-evoked responses in PC12 phaeochromocytoma cells.
Br J Pharmacol. 1991 Apr;102(4):851-4
PMID: 1855114
-
Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters.
Arch Int Pharmacodyn Ther. 1963;143:299-330
PMID: 13996119
-
Purinoceptor-mediated modulation by endogenous and exogenous agonists of stimulation-evoked [3H]noradrenaline release on rat iris.
Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):417-23
PMID: 1320209
-
ATP modulates the efferent function of capsaicin-sensitive neurones in guinea-pig isolated atria.
Br J Pharmacol. 1992 Mar;105(3):516-20
PMID: 1628140